{"id":"https://openalex.org/W2440468425","doi":null,"title":"Adoptive cell therapy for metastatic melanoma patients: pre-clinical development at the Sheba Medical Center.","display_name":"Adoptive cell therapy for metastatic melanoma patients: pre-clinical development at the Sheba Medical Center.","alternate_titles":[],"publication_year":2006,"publication_date":"2006-03-01","ids":{"openalex":"https://openalex.org/W2440468425","mag":"2440468425","pmid":"https://pubmed.ncbi.nlm.nih.gov/16599050"},"language":"en","primary_location":{"id":"pmid:16599050","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16599050","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Israel Medical Association journal : IMAJ","raw_type":"Comparative Study"},"parent_works":[],"lineage":["https://openalex.org/W2440468425"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055924804","display_name":"Michal Judith Besser","orcid":"https://orcid.org/0000-0002-9233-0458","observed_orcids":["https://orcid.org/0000-0002-9233-0458"]},"institutions":[{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Michal J Besser","raw_affiliation_strings":["Ella Institute for Treatment and Research of Melanoma, Sheba Medical Center, Tel Hashomer, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ella Institute for Treatment and Research of Melanoma, Sheba Medical Center, Tel Hashomer, Israel","institution_ids":["https://openalex.org/I2799810450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113460281","display_name":"Avraham J. Treves","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Avraham J Treves","raw_affiliation_strings":["Cancer Research Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Center","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064670126","display_name":"Orit Itzhaki","orcid":"https://orcid.org/0000-0002-6882-9603","observed_orcids":["https://orcid.org/0000-0002-6882-9603"]},"institutions":[{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Orit Itzhaki","raw_affiliation_strings":["Sheba Medical Center at Tel Hashomer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sheba Medical Center at Tel Hashomer","institution_ids":["https://openalex.org/I2799810450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020369336","display_name":"Izhar Hardan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Izhar Hardan","raw_affiliation_strings":["Sheba Medical Center at Tel Hashomer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sheba Medical Center at Tel Hashomer","institution_ids":["https://openalex.org/I2799810450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058925624","display_name":"Arnon Nagler","orcid":"https://orcid.org/0000-0002-0763-1265","observed_orcids":["https://orcid.org/0000-0002-0763-1265"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arnon Nagler","raw_affiliation_strings":["Hematology Division"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Division","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110160515","display_name":"Moshe Zvi Papa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Moshe Z Papa","raw_affiliation_strings":["Sheba Medical Center at Tel Hashomer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sheba Medical Center at Tel Hashomer","institution_ids":["https://openalex.org/I2799810450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036144155","display_name":"Raphael Catane","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raphael Catane","raw_affiliation_strings":["Breast Cancer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast Cancer","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108241588","display_name":"Eyal Winkler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Eyal Winkler","raw_affiliation_strings":["Sheba Medical Center at Tel Hashomer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sheba Medical Center at Tel Hashomer","institution_ids":["https://openalex.org/I2799810450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019908482","display_name":"Bruria Shalmon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Bruria Shalmon-Zifroni","raw_affiliation_strings":["Sheba Medical Center at Tel Hashomer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sheba Medical Center at Tel Hashomer","institution_ids":["https://openalex.org/I2799810450"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026967523","display_name":"Jacob Schachter","orcid":"https://orcid.org/0000-0001-8674-6476","observed_orcids":["https://orcid.org/0000-0001-8674-6476"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jacob Schachter","raw_affiliation_strings":["Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5445,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.61822565,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"8","issue":"3","first_page":"164","last_page":"168"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6093999743461609,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6093999743461609,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.23520000278949738,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.05939999967813492,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.9729999899864197},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9909999966621399},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.996999979019165},{"id":"https://openalex.org/keywords/til-expansion","display_name":"TIL expansion","score":0.6650000214576721},{"id":"https://openalex.org/keywords/preclinical-drug-development","display_name":"preclinical drug development","score":0.7440000176429749},{"id":"https://openalex.org/keywords/autologous-tumor-cells","display_name":"autologous tumor cells","score":0.7160000205039978},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7229999899864197}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9624624252319336},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.719982922077179},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.5955869555473328},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5608110427856445},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5512691736221313},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5397412180900574},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5039862990379333},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4187431037425995},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.15140452980995178}],"mesh":[{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016131","descriptor_name":"Lymphocyte Subsets","qualifier_ui":"Q000637","qualifier_name":"transplantation","is_major_topic":false},{"descriptor_ui":"D016246","descriptor_name":"Lymphocytes, Tumor-Infiltrating","qualifier_ui":"Q000637","qualifier_name":"transplantation","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019264","descriptor_name":"Adoptive Transfer","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:16599050","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16599050","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Israel Medical Association journal : IMAJ","raw_type":"Comparative Study"},{"id":"mag:2440468425","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16599050","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1992699637","https://openalex.org/W2014865000","https://openalex.org/W2058899594","https://openalex.org/W2106511557","https://openalex.org/W2148523692","https://openalex.org/W2151246207","https://openalex.org/W2164364292","https://openalex.org/W2427422967"],"related_works":["https://openalex.org/W2602546263","https://openalex.org/W2162184613","https://openalex.org/W2966856673","https://openalex.org/W2107321795","https://openalex.org/W2766802590","https://openalex.org/W2001306761","https://openalex.org/W2295358499","https://openalex.org/W2566961482","https://openalex.org/W2101303761","https://openalex.org/W2895610076"],"abstract_inverted_index":{"BACKGROUND:":[0],"Metastatic":[1],"melanoma":[2,114,132,204],"is":[3,20,58,199],"an":[4,85,98],"aggressive":[5],"and":[6,133,147,196],"highly":[7],"malignant":[8],"cancer.":[9],"The":[10,73],"5":[11,164,174],"year":[12],"survival":[13,27],"rate":[14,50],"of":[15,28,51,56,76,88,91,103,184],"patients":[16,115,144,166,175,205],"with":[17,24,43,61,128],"metastatic":[18,113,203],"disease":[19],"less":[21],"than":[22],"5%":[23],"a":[25,37,48,189],"median":[26],"only":[29],"6-10":[30],"months.":[31],"Drugs":[32],"like":[33],"dacarbazin":[34],"(DTIC)":[35],"as":[36],"single":[38],"agent":[39],"or":[40],"in":[41,97,101,116,188],"combination":[42],"other":[44],"chemotherapy":[45],"agents":[46],"have":[47],"response":[49,57],"15-30%,":[52],"but":[53],"the":[54,108,154,168,179,185,207],"duration":[55],"usually":[59],"short":[60],"no":[62],"impact":[63],"on":[64],"survival.":[65],"Interleukin-2-based":[66],"immunotherapy":[67],"has":[68],"shown":[69],"more":[70],"promising":[71],"results.":[72],"National":[74],"Institutes":[75],"Health":[77],"recently":[78],"reported":[79],"that":[80],"lymphodepleting":[81],"chemotherapy,":[82],"followed":[83],"by":[84],"adoptive":[86],"transfer":[87],"large":[89,137],"numbers":[90],"anti-tumor":[92,170],"specific":[93,129,151],"tumor-infiltrating":[94],"lymphocytes,":[95],"resulted":[96],"objective":[99],"regression":[100],"51%":[102],"patients.":[104],"OBJECTIVES:":[105],"To":[106],"introduce":[107],"TIL":[109,121,140,160,186],"technology":[110,187],"to":[111,136],"advanced":[112],"Israel.":[117],"METHODS:":[118],"We":[119],"generated":[120],"cultures":[122,141,161],"from":[123,142,163],"tumor":[124,157],"tissue,":[125],"choosing":[126],"those":[127,173],"activity":[130,152],"against":[131,153],"expanding":[134],"them":[135],"numbers.":[138],"RESULTS:":[139],"nine":[143],"were":[145,193],"established":[146],"examined":[148],"for":[149,178,201],"their":[150],"patients'":[155],"autologous":[156],"cells.":[158],"Twelve":[159],"derived":[162],"different":[165],"showed":[167],"desired":[169],"activity,":[171],"making":[172],"potential":[176],"candidates":[177],"therapy.":[180],"CONCLUSIONS:":[181],"Pre-clinical":[182],"studies":[183],"clinical":[190],"laboratory":[191],"set-up":[192],"performed":[194],"successfully":[195],"this":[197],"modality":[198],"ready":[200],"treating":[202],"at":[206],"Sheba":[208],"Medical":[209],"Center's":[210],"Ella":[211],"Institute.":[212]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2440468425","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
